You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Harvard Business School
Dow
McKinsey
Merck

Last Updated: March 31, 2020

DrugPatentWatch Database Preview

METHYLPREDNISOLONE ACETATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Methylprednisolone Acetate, and what generic alternatives are available?

Methylprednisolone Acetate is a drug marketed by Akorn, Amneal, Sagent Pharms Inc, Sandoz Inc, Teva Pharms Usa, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in METHYLPREDNISOLONE ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.

US ANDA Litigation and Generic Entry Outlook for Methylprednisolone Acetate

A generic version of METHYLPREDNISOLONE ACETATE was approved as methylprednisolone acetate by TEVA PHARMS USA on February 23rd, 2005.

  Start Trial

Drug patent expirations by year for METHYLPREDNISOLONE ACETATE
Drug Sales Revenue Trends for METHYLPREDNISOLONE ACETATE

See drug sales revenues for METHYLPREDNISOLONE ACETATE

Recent Clinical Trials for METHYLPREDNISOLONE ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hadassah Medical OrganizationPhase 2
Northwestern UniversityPhase 4
The University of Texas Medical Branch, GalvestonPhase 2

See all METHYLPREDNISOLONE ACETATE clinical trials

Pharmacology for METHYLPREDNISOLONE ACETATE
Synonyms for METHYLPREDNISOLONE ACETATE
(6.alpha.,11.beta.)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
11,17-Dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate, (6.alpha.,11.beta.)- #
11.beta.,17,21-Trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate
200M356
43502P7F0P
53-36-1
54299-EP2308562A2
54299-EP2371811A2
6-METHYLPREDNISOLONE ACETATE
6.alpha.-Methylprednisolone 21-acetate
6.alpha.-Methylprednisolone acetate
6alpha-Methyl Prednisolone 21-Acetate
6alpha-Methylprednisolone 21-acetate
6alpha-Methylprednisolone acetate
A19446
AB0013042
AB00375925-05
AC-14387
AC-18907
acetyl-methylprednisolone
AKOS015961639
AKOS015969745
AKOS025401472
AKOS030242401
AS-13140
BCP11934
BDBM233194
C-22293
C08179
CAS-53-36-1
CC-30908
CHEBI:6889
CHEMBL1364144
component of Neo-Medrol
CPD000718757
CTK4J7749
D-Med
D00979
depMedalone 40
depMedalone 80
Depo-Medrate
Depo-Medrin
Depo-medrol
Depo-medrol (TN)
Depo-Medrone
Depo-methylprednisolone
Depo-Methylprednisolone acetate
Depomedrone
Depometicort
Depot-Medrol
DSSTox_CID_3302
DSSTox_GSID_23302
DSSTox_RID_76966
DTXSID7023302
EINECS 200-171-3
H421
HMS2233N14
HMS3259L07
Lemod Depo
LS-118505
M-Predrol
MCULE-6383206380
Medrol acetate
Medrol Enpak
Mepred
methyl prednisolone 21-acetate
Methyl prednisolone acetate
Methylprednisolon-21-acetat
Methylprednisolone 21-acetate
Methylprednisolone 21-acetate; Depo-medrate
Methylprednisolone acetate (JAN/USP)
Methylprednisolone acetate [USAN:JAN]
Methylprednisolone acetate [USP:JAN]
Methylprednisolone EP Impurity J
methylprednisolone-21-acetate
MLS001304003
MLS002667229
NC00628
NCGC00159503-02
Neo-Medrol (Salt/Mix)
NSC 48985
NSC-48985
NSC48985
PLBHSZGDDKCEHR-LFYFAGGJSA-N
PLBHSZGDDKCEHR-UHFFFAOYSA-N
Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate
Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate (8CI)
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6-alpha,11-beta)-
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
Q27107351
SAM002699893
SCHEMBL13231
SCHEMBL145794
SCHEMBL1657958
SCHEMBL3437554
SMR000718757
SMR001556998
Solsolona
Solsolona [inj.]
Tox21_111722
U 8210
Ubrason
Ubrason [inj.]
Unidrol
UNII-43502P7F0P
Urbason crystal suspension
Vetacortyl
ZINC118912449

US Patents and Regulatory Information for METHYLPREDNISOLONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 086903-001 Oct 20, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 085374-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sagent Pharms Inc METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 201835-003 Jun 27, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 210043-002 May 20, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 040557-001 Feb 23, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 085595-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz Inc METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 040719-001 Jan 29, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Harvard Business School
Dow
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.